The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rhizoma Gastrodiae Tablets Market Research Report 2025
Synopsis
Rhizoma Gastrodiae Tablets can dispel wind and dampness, relax tendons and collaterals, promote blood circulation and relieve pain. Used for limb constriction, numbness of hands and feet, soreness of waist and leg.
The global Rhizoma Gastrodiae Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rhizoma Gastrodiae Tablets include Zhaotong Huacheng Pharmaceutical, Guangdong Luofushan National Pharmaceutical, Tongrentang Chinese Medicine, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Lanzhou Foci Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical and Tsumura & Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rhizoma Gastrodiae Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rhizoma Gastrodiae Tablets.
Report Scope
The Rhizoma Gastrodiae Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rhizoma Gastrodiae Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rhizoma Gastrodiae Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zhaotong Huacheng Pharmaceutical
Guangdong Luofushan National Pharmaceutical
Tongrentang Chinese Medicine
Guizhou Bailing
Guangxi Chanfang Pharmaceutical
Lanzhou Foci Pharmaceutical
Shaanxi Tianyang Pharmaceutical
Taiji Group Sichuan Mianyang Pharmaceutical
Tsumura & Co.
Segment by Type
Gastrodia elata f.glauca
G.elata.BI.f elata
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rhizoma Gastrodiae Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rhizoma Gastrodiae Tablets can dispel wind and dampness, relax tendons and collaterals, promote blood circulation and relieve pain. Used for limb constriction, numbness of hands and feet, soreness of waist and leg.
The global Rhizoma Gastrodiae Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rhizoma Gastrodiae Tablets include Zhaotong Huacheng Pharmaceutical, Guangdong Luofushan National Pharmaceutical, Tongrentang Chinese Medicine, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Lanzhou Foci Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical and Tsumura & Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rhizoma Gastrodiae Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rhizoma Gastrodiae Tablets.
Report Scope
The Rhizoma Gastrodiae Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rhizoma Gastrodiae Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rhizoma Gastrodiae Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zhaotong Huacheng Pharmaceutical
Guangdong Luofushan National Pharmaceutical
Tongrentang Chinese Medicine
Guizhou Bailing
Guangxi Chanfang Pharmaceutical
Lanzhou Foci Pharmaceutical
Shaanxi Tianyang Pharmaceutical
Taiji Group Sichuan Mianyang Pharmaceutical
Tsumura & Co.
Segment by Type
Gastrodia elata f.glauca
G.elata.BI.f elata
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rhizoma Gastrodiae Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rhizoma Gastrodiae Tablets Market Overview
1.1 Product Overview and Scope of Rhizoma Gastrodiae Tablets
1.2 Rhizoma Gastrodiae Tablets Segment by Type
1.2.1 Global Rhizoma Gastrodiae Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Gastrodia elata f.glauca
1.2.3 G.elata.BI.f elata
1.2.4 Other
1.3 Rhizoma Gastrodiae Tablets Segment by Application
1.3.1 Global Rhizoma Gastrodiae Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Rhizoma Gastrodiae Tablets Market Size Estimates and Forecasts
1.4.1 Global Rhizoma Gastrodiae Tablets Revenue 2019-2030
1.4.2 Global Rhizoma Gastrodiae Tablets Sales 2019-2030
1.4.3 Global Rhizoma Gastrodiae Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rhizoma Gastrodiae Tablets Market Competition by Manufacturers
2.1 Global Rhizoma Gastrodiae Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rhizoma Gastrodiae Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Rhizoma Gastrodiae Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rhizoma Gastrodiae Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rhizoma Gastrodiae Tablets, Product Type & Application
2.7 Rhizoma Gastrodiae Tablets Market Competitive Situation and Trends
2.7.1 Rhizoma Gastrodiae Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rhizoma Gastrodiae Tablets Players Market Share by Revenue
2.7.3 Global Rhizoma Gastrodiae Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rhizoma Gastrodiae Tablets Retrospective Market Scenario by Region
3.1 Global Rhizoma Gastrodiae Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rhizoma Gastrodiae Tablets Global Rhizoma Gastrodiae Tablets Sales by Region: 2019-2030
3.2.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2019-2024
3.2.2 Global Rhizoma Gastrodiae Tablets Sales by Region: 2025-2030
3.3 Global Rhizoma Gastrodiae Tablets Global Rhizoma Gastrodiae Tablets Revenue by Region: 2019-2030
3.3.1 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2019-2024
3.3.2 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2025-2030
3.4 North America Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
3.4.1 North America Rhizoma Gastrodiae Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rhizoma Gastrodiae Tablets Sales by Country (2019-2030)
3.4.3 North America Rhizoma Gastrodiae Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
3.5.1 Europe Rhizoma Gastrodiae Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rhizoma Gastrodiae Tablets Sales by Country (2019-2030)
3.5.3 Europe Rhizoma Gastrodiae Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Rhizoma Gastrodiae Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rhizoma Gastrodiae Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Rhizoma Gastrodiae Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
3.7.1 Latin America Rhizoma Gastrodiae Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rhizoma Gastrodiae Tablets Sales by Country (2019-2030)
3.7.3 Latin America Rhizoma Gastrodiae Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rhizoma Gastrodiae Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Rhizoma Gastrodiae Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rhizoma Gastrodiae Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rhizoma Gastrodiae Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2019-2030)
4.1.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2019-2024)
4.1.2 Global Rhizoma Gastrodiae Tablets Sales by Type (2025-2030)
4.1.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2019-2030)
4.2 Global Rhizoma Gastrodiae Tablets Revenue by Type (2019-2030)
4.2.1 Global Rhizoma Gastrodiae Tablets Revenue by Type (2019-2024)
4.2.2 Global Rhizoma Gastrodiae Tablets Revenue by Type (2025-2030)
4.2.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Rhizoma Gastrodiae Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2019-2030)
5.1.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2019-2024)
5.1.2 Global Rhizoma Gastrodiae Tablets Sales by Application (2025-2030)
5.1.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2019-2030)
5.2 Global Rhizoma Gastrodiae Tablets Revenue by Application (2019-2030)
5.2.1 Global Rhizoma Gastrodiae Tablets Revenue by Application (2019-2024)
5.2.2 Global Rhizoma Gastrodiae Tablets Revenue by Application (2025-2030)
5.2.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Rhizoma Gastrodiae Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zhaotong Huacheng Pharmaceutical
6.1.1 Zhaotong Huacheng Pharmaceutical Corporation Information
6.1.2 Zhaotong Huacheng Pharmaceutical Description and Business Overview
6.1.3 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.1.5 Zhaotong Huacheng Pharmaceutical Recent Developments/Updates
6.2 Guangdong Luofushan National Pharmaceutical
6.2.1 Guangdong Luofushan National Pharmaceutical Corporation Information
6.2.2 Guangdong Luofushan National Pharmaceutical Description and Business Overview
6.2.3 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.2.5 Guangdong Luofushan National Pharmaceutical Recent Developments/Updates
6.3 Tongrentang Chinese Medicine
6.3.1 Tongrentang Chinese Medicine Corporation Information
6.3.2 Tongrentang Chinese Medicine Description and Business Overview
6.3.3 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio
6.3.5 Tongrentang Chinese Medicine Recent Developments/Updates
6.4 Guizhou Bailing
6.4.1 Guizhou Bailing Corporation Information
6.4.2 Guizhou Bailing Description and Business Overview
6.4.3 Guizhou Bailing Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio
6.4.5 Guizhou Bailing Recent Developments/Updates
6.5 Guangxi Chanfang Pharmaceutical
6.5.1 Guangxi Chanfang Pharmaceutical Corporation Information
6.5.2 Guangxi Chanfang Pharmaceutical Description and Business Overview
6.5.3 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.5.5 Guangxi Chanfang Pharmaceutical Recent Developments/Updates
6.6 Lanzhou Foci Pharmaceutical
6.6.1 Lanzhou Foci Pharmaceutical Corporation Information
6.6.2 Lanzhou Foci Pharmaceutical Description and Business Overview
6.6.3 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.6.5 Lanzhou Foci Pharmaceutical Recent Developments/Updates
6.7 Shaanxi Tianyang Pharmaceutical
6.6.1 Shaanxi Tianyang Pharmaceutical Corporation Information
6.6.2 Shaanxi Tianyang Pharmaceutical Description and Business Overview
6.6.3 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.7.5 Shaanxi Tianyang Pharmaceutical Recent Developments/Updates
6.8 Taiji Group Sichuan Mianyang Pharmaceutical
6.8.1 Taiji Group Sichuan Mianyang Pharmaceutical Corporation Information
6.8.2 Taiji Group Sichuan Mianyang Pharmaceutical Description and Business Overview
6.8.3 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
6.8.5 Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments/Updates
6.9 Tsumura & Co.
6.9.1 Tsumura & Co. Corporation Information
6.9.2 Tsumura & Co. Description and Business Overview
6.9.3 Tsumura & Co. Rhizoma Gastrodiae Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio
6.9.5 Tsumura & Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rhizoma Gastrodiae Tablets Industry Chain Analysis
7.2 Rhizoma Gastrodiae Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rhizoma Gastrodiae Tablets Production Mode & Process
7.4 Rhizoma Gastrodiae Tablets Sales and Marketing
7.4.1 Rhizoma Gastrodiae Tablets Sales Channels
7.4.2 Rhizoma Gastrodiae Tablets Distributors
7.5 Rhizoma Gastrodiae Tablets Customers
8 Rhizoma Gastrodiae Tablets Market Dynamics
8.1 Rhizoma Gastrodiae Tablets Industry Trends
8.2 Rhizoma Gastrodiae Tablets Market Drivers
8.3 Rhizoma Gastrodiae Tablets Market Challenges
8.4 Rhizoma Gastrodiae Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rhizoma Gastrodiae Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rhizoma Gastrodiae Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rhizoma Gastrodiae Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rhizoma Gastrodiae Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rhizoma Gastrodiae Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rhizoma Gastrodiae Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rhizoma Gastrodiae Tablets Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rhizoma Gastrodiae Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rhizoma Gastrodiae Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rhizoma Gastrodiae Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Rhizoma Gastrodiae Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rhizoma Gastrodiae Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rhizoma Gastrodiae Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rhizoma Gastrodiae Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rhizoma Gastrodiae Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Rhizoma Gastrodiae Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Rhizoma Gastrodiae Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Rhizoma Gastrodiae Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Rhizoma Gastrodiae Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rhizoma Gastrodiae Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Rhizoma Gastrodiae Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Rhizoma Gastrodiae Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rhizoma Gastrodiae Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rhizoma Gastrodiae Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rhizoma Gastrodiae Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rhizoma Gastrodiae Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rhizoma Gastrodiae Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rhizoma Gastrodiae Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rhizoma Gastrodiae Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rhizoma Gastrodiae Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rhizoma Gastrodiae Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rhizoma Gastrodiae Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rhizoma Gastrodiae Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rhizoma Gastrodiae Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rhizoma Gastrodiae Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rhizoma Gastrodiae Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rhizoma Gastrodiae Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rhizoma Gastrodiae Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rhizoma Gastrodiae Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rhizoma Gastrodiae Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rhizoma Gastrodiae Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rhizoma Gastrodiae Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rhizoma Gastrodiae Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rhizoma Gastrodiae Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Rhizoma Gastrodiae Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Type (2019-2024)
Table 59. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Type (2025-2030)
Table 60. Global Rhizoma Gastrodiae Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Rhizoma Gastrodiae Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Application (2019-2024)
Table 69. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Application (2025-2030)
Table 70. Zhaotong Huacheng Pharmaceutical Corporation Information
Table 71. Zhaotong Huacheng Pharmaceutical Description and Business Overview
Table 72. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 74. Zhaotong Huacheng Pharmaceutical Recent Developments/Updates
Table 75. Guangdong Luofushan National Pharmaceutical Corporation Information
Table 76. Guangdong Luofushan National Pharmaceutical Description and Business Overview
Table 77. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 79. Guangdong Luofushan National Pharmaceutical Recent Developments/Updates
Table 80. Tongrentang Chinese Medicine Corporation Information
Table 81. Tongrentang Chinese Medicine Description and Business Overview
Table 82. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product
Table 84. Tongrentang Chinese Medicine Recent Developments/Updates
Table 85. Guizhou Bailing Corporation Information
Table 86. Guizhou Bailing Description and Business Overview
Table 87. Guizhou Bailing Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Guizhou Bailing Rhizoma Gastrodiae Tablets Product
Table 89. Guizhou Bailing Recent Developments/Updates
Table 90. Guangxi Chanfang Pharmaceutical Corporation Information
Table 91. Guangxi Chanfang Pharmaceutical Description and Business Overview
Table 92. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 94. Guangxi Chanfang Pharmaceutical Recent Developments/Updates
Table 95. Lanzhou Foci Pharmaceutical Corporation Information
Table 96. Lanzhou Foci Pharmaceutical Description and Business Overview
Table 97. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 99. Lanzhou Foci Pharmaceutical Recent Developments/Updates
Table 100. Shaanxi Tianyang Pharmaceutical Corporation Information
Table 101. Shaanxi Tianyang Pharmaceutical Description and Business Overview
Table 102. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 104. Shaanxi Tianyang Pharmaceutical Recent Developments/Updates
Table 105. Taiji Group Sichuan Mianyang Pharmaceutical Corporation Information
Table 106. Taiji Group Sichuan Mianyang Pharmaceutical Description and Business Overview
Table 107. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product
Table 109. Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments/Updates
Table 110. Tsumura & Co. Corporation Information
Table 111. Tsumura & Co. Description and Business Overview
Table 112. Tsumura & Co. Rhizoma Gastrodiae Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Tsumura & Co. Rhizoma Gastrodiae Tablets Product
Table 114. Tsumura & Co. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Rhizoma Gastrodiae Tablets Distributors List
Table 118. Rhizoma Gastrodiae Tablets Customers List
Table 119. Rhizoma Gastrodiae Tablets Market Trends
Table 120. Rhizoma Gastrodiae Tablets Market Drivers
Table 121. Rhizoma Gastrodiae Tablets Market Challenges
Table 122. Rhizoma Gastrodiae Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rhizoma Gastrodiae Tablets
Figure 2. Global Rhizoma Gastrodiae Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rhizoma Gastrodiae Tablets Market Share by Type in 2023 & 2030
Figure 4. Gastrodia elata f.glauca Product Picture
Figure 5. G.elata.BI.f elata Product Picture
Figure 6. Other Product Picture
Figure 7. Global Rhizoma Gastrodiae Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Rhizoma Gastrodiae Tablets Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Rhizoma Gastrodiae Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Rhizoma Gastrodiae Tablets Market Size (2019-2030) & (US$ Million)
Figure 14. Global Rhizoma Gastrodiae Tablets Sales (2019-2030) & (K Units)
Figure 15. Global Rhizoma Gastrodiae Tablets Average Price (USD/Unit) & (2019-2030)
Figure 16. Rhizoma Gastrodiae Tablets Report Years Considered
Figure 17. Rhizoma Gastrodiae Tablets Sales Share by Manufacturers in 2023
Figure 18. Global Rhizoma Gastrodiae Tablets Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Rhizoma Gastrodiae Tablets Players: Market Share by Revenue in 2023
Figure 20. Rhizoma Gastrodiae Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Rhizoma Gastrodiae Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Rhizoma Gastrodiae Tablets Sales Market Share by Country (2019-2030)
Figure 23. North America Rhizoma Gastrodiae Tablets Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Rhizoma Gastrodiae Tablets Sales Market Share by Country (2019-2030)
Figure 27. Europe Rhizoma Gastrodiae Tablets Revenue Market Share by Country (2019-2030)
Figure 28. Germany Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Rhizoma Gastrodiae Tablets Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2019-2030)
Figure 35. China Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Rhizoma Gastrodiae Tablets Sales Market Share by Country (2019-2030)
Figure 46. Latin America Rhizoma Gastrodiae Tablets Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Rhizoma Gastrodiae Tablets Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Rhizoma Gastrodiae Tablets Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Rhizoma Gastrodiae Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Rhizoma Gastrodiae Tablets by Type (2019-2030)
Figure 56. Global Revenue Market Share of Rhizoma Gastrodiae Tablets by Type (2019-2030)
Figure 57. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Rhizoma Gastrodiae Tablets by Application (2019-2030)
Figure 59. Global Revenue Market Share of Rhizoma Gastrodiae Tablets by Application (2019-2030)
Figure 60. Global Rhizoma Gastrodiae Tablets Price (USD/Unit) by Application (2019-2030)
Figure 61. Rhizoma Gastrodiae Tablets Value Chain
Figure 62. Rhizoma Gastrodiae Tablets Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
